(Q33184380)

English

Receptor tyrosine kinases as rational targets for prostate cancer treatment: platelet-derived growth factor receptor and imatinib mesylate

scientific article

In more languages
default values for all languages
No label defined

No description defined

Statements

Receptor tyrosine kinases as rational targets for prostate cancer treatment: platelet-derived growth factor receptor and imatinib mesylate (English)
115-21; discussion 122

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit